Mechanisms of Disease:: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease

被引:127
作者
Díez, J
González, A
López, B
Querejeta, R
机构
[1] Univ Navarra, Area Fisiopatol Cardiovasc, Ctr Appl Med Res, Pamplona 31008, Spain
[2] Donostia Univ Hosp, Div Cardiol, San Sebastian, Spain
来源
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2005年 / 2卷 / 04期
关键词
arterial hypertension; collagen; fibrosis; left-ventricular hypertrophy;
D O I
10.1038/ncpcardio0158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Changes in the composition of cardiac tissue develop in arterial hypertension and lead to structural remodeling of the myocardium. Structural remodeling is the consequence of a number of pathologic processes, mediated. by mechanical, neurohormonal and cytokine routes, occurring in the cardiomyocyte and the noncardiomyocyte compartments of the heart. Ono of these processes is related to the disruption of the equilibrium between the synthesis and degradation of collagen type I and III moleculcs, which results in an excessive accumulation of collagen type I and III fibers in the interstitium and the perivascular regions of the myocardium. The clinical relevance of ventricular fibrosis is that it might contribute to the increased cardiac risk of patients with hypertensive heart disease. This review focuses on the mechanisms of hypertensive ventricular fibrosis and its clinical consequences. In addition, we discuss the noninvasive methods for the diagnosis of cardiac fibrosis and the therapeutic strategies aimed to promote its reduction.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 57 条
  • [1] Aldosteronism and peripheral blood mononuclear cell activation - A neuroendocrine-immune interface
    Ahokas, RA
    Warrington, KJ
    Gerling, IC
    Sun, Y
    Wodi, LA
    Herring, PA
    Lu, L
    Bhattacharya, SK
    Postlethwaite, AE
    Weber, KT
    [J]. CIRCULATION RESEARCH, 2003, 93 (10) : E124 - E135
  • [2] AMANUMA S, 1994, POSTGRAD MED J, V70, pS67
  • [3] Bethge C, 1987, J Cardiovasc Pharmacol, V10 Suppl 6, pS119, DOI 10.1097/00005344-198700106-00016
  • [4] Regulation of cardiovascular collagen synthesis by mechanical load
    Bishop, JE
    Lindahl, G
    [J]. CARDIOVASCULAR RESEARCH, 1999, 42 (01) : 27 - 44
  • [5] Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease
    Boldt, A
    Wetzel, U
    Lauschke, J
    Weigl, J
    Gummert, J
    Hindricks, G
    Kottkamp, H
    Dhein, S
    [J]. HEART, 2004, 90 (04) : 400 - 405
  • [6] ANTIFIBROTIC EFFECTS OF SPIRONOLACTONE IN PREVENTING MYOCARDIAL FIBROSIS IN SYSTEMIC ARTERIAL-HYPERTENSION
    BRILLA, CG
    MATSUBARA, LS
    WEBER, KT
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (03) : A12 - A16
  • [7] Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
    Brilla, CG
    Funck, RC
    Rupp, H
    [J]. CIRCULATION, 2000, 102 (12) : 1388 - 1393
  • [8] CARDIOREPARATIVE EFFECTS OF LISINOPRIL IN RATS WITH GENETIC-HYPERTENSION AND LEFT-VENTRICULAR HYPERTROPHY
    BRILLA, CG
    JANICKI, JS
    WEBER, KT
    [J]. CIRCULATION, 1991, 83 (05) : 1771 - 1779
  • [9] COLLAGEN-METABOLISM IN CULTURED ADULT-RAT CARDIAC FIBROBLASTS - RESPONSE TO ANGIOTENSIN-II AND ALDOSTERONE
    BRILLA, CG
    ZHOU, GP
    MATSUBARA, L
    WEBER, KT
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (07) : 809 - 820
  • [10] Burlew Brad S., 2000, Cardiology Clinics, V18, P435, DOI 10.1016/S0733-8651(05)70154-5